Xianbin Tian

1.3k total citations
33 papers, 972 citations indexed

About

Xianbin Tian is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Xianbin Tian has authored 33 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Pediatrics, Perinatology and Child Health and 8 papers in Pharmacology. Recurrent topics in Xianbin Tian's work include Drug Transport and Resistance Mechanisms (13 papers), Pharmacological Effects and Toxicity Studies (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Xianbin Tian is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Pharmacological Effects and Toxicity Studies (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Xianbin Tian collaborates with scholars based in United States, Switzerland and Netherlands. Xianbin Tian's co-authors include Kim L. R. Brouwer, Maciej J. Zamek‐Gliszczynski, Ken-ichi Nezasa, Nita Patel, Thomas J. Raub, Arlene S. Bridges, Peijin Zhang, Gary D. Kruh, Martin G. Belinsky and Joan E. Humphreys and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Xianbin Tian

33 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xianbin Tian United States	19	579	298	291	216	118	33	972
Manfred G. Ismair Switzerland	12	957 1.7×	265 0.9×	485 1.7×	272 1.3×	102 0.9×	15	1.3k
Kathleen Köck United States	21	991 1.7×	358 1.2×	427 1.5×	311 1.4×	149 1.3×	28	1.5k
Cornelia M.M. van der Kruijssen Netherlands	14	647 1.1×	375 1.3×	295 1.0×	315 1.5×	78 0.7×	17	1.0k
Robert A.B. van Waterschoot Netherlands	16	725 1.3×	419 1.4×	233 0.8×	332 1.5×	50 0.4×	20	1.2k
Takenori Niioka Japan	20	320 0.6×	202 0.7×	220 0.8×	166 0.8×	73 0.6×	72	1.0k
J. H. Beijnen Netherlands	20	810 1.4×	176 0.6×	305 1.0×	412 1.9×	88 0.7×	47	1.4k
Cristi R. King United States	12	564 1.0×	538 1.8×	172 0.6×	379 1.8×	53 0.4×	17	1.2k
Pauline Breedveld Netherlands	8	778 1.3×	149 0.5×	374 1.3×	269 1.2×	55 0.5×	9	1.1k
Nicola F. Smith United States	16	605 1.0×	243 0.8×	222 0.8×	618 2.9×	60 0.5×	22	1.3k

Countries citing papers authored by Xianbin Tian

Since Specialization

Citations

This map shows the geographic impact of Xianbin Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianbin Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianbin Tian more than expected).

Fields of papers citing papers by Xianbin Tian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianbin Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianbin Tian. The network helps show where Xianbin Tian may publish in the future.

Co-authorship network of co-authors of Xianbin Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Xianbin Tian. A scholar is included among the top collaborators of Xianbin Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianbin Tian. Xianbin Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sahasranaman, Srikumar, Xianbin Tian, Ying Fei Li, et al.. (2025). Clinical Pharmacology Overview of Tislelizumab in Patients With Advanced Tumors With a Focus on Racial Impact. Clinical and Translational Science. 18(5). e70221–e70221. 3 indexed citations

Zhu, Rui, Rik C. Schoemaker, Xianbin Tian, et al.. (2024). Model‐based comparisons of post‐treatment free IgE and FEV1 between omalizumab asthma dosing tables in the United States and European Union. British Journal of Clinical Pharmacology. 90(12). 3190–3200. 1 indexed citations

Zhu, Rui, Ryan Owen, Justin Wilkins, et al.. (2021). Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polyps. Pulmonary Pharmacology & Therapeutics. 71. 102080–102080. 2 indexed citations

Hijiya, Nobuko, C. Michel Zwaan, Carmelo Rizzari, et al.. (2019). Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome–Positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia. Clinical Cancer Research. 26(4). 812–820. 23 indexed citations

Hanna, Imad, Joseph Schoepfer, Tapan Ray, et al.. (2019). Disposition of asciminib, a potent BCR-ABL1 tyrosine kinase inhibitor, in healthy male subjects. Xenobiotica. 50(2). 160–179. 19 indexed citations

Wang, Mengmeng, Xianbin Tian, Louis Leung, et al.. (2011). Comparative Pharmacokinetics and Metabolism Studies in Lean and Diet- Induced Obese Mice: An Animal Efficacy Model for 11β -Hydroxysteroid Dehydrogenase Type 1 (11β -HSD1) Inhibitors. Drug Metabolism Letters. 5(1). 55–63. 6 indexed citations

Swift, Brandon, Xianbin Tian, & Kim L. R. Brouwer. (2009). Integration of Preclinical and Clinical Data with Pharmacokinetic Modeling and Simulation to Evaluate Fexofenadine as a Probe for Hepatobiliary Transport Function. Pharmaceutical Research. 26(8). 1942–1951. 15 indexed citations

Tian, Xianbin, Brandon Swift, Maciej J. Zamek‐Gliszczynski, et al.. (2008). Impact of Basolateral Multidrug Resistance-Associated Protein (Mrp) 3 and Mrp4 on the Hepatobiliary Disposition of Fexofenadine in Perfused Mouse Livers. Drug Metabolism and Disposition. 36(5). 911–915. 34 indexed citations

Vugmeyster, Yulia, Xianbin Tian, Pamela Szklut, Marion T. Kasaian, & Xin Xu. (2008). Pharmacokinetic and Pharmacodynamic Modeling of a Humanized Anti-IL-13 Antibody in Naive and Ascaris-Challenged Cynomolgus Monkeys. Pharmaceutical Research. 26(2). 306–315. 15 indexed citations

10.

Tian, Xianbin, Maciej J. Zamek‐Gliszczynski, Jun Li, et al.. (2007). Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice. Drug Metabolism and Disposition. 36(1). 61–64. 37 indexed citations

11.

Nezasa, Ken-ichi, Xianbin Tian, Maciej J. Zamek‐Gliszczynski, et al.. (2006). ALTERED HEPATOBILIARY DISPOSITION OF 5 (AND 6)-CARBOXY-2′,7′-DICHLOROFLUORESCEIN IN Abcg2 (Bcrp1) AND Abcc2 (Mrp2) KNOCKOUT MICE. Drug Metabolism and Disposition. 34(4). 718–723. 41 indexed citations

12.

Tian, Xianbin, David L. Bourdet, Richard Ho, et al.. (2006). Ritonavir, Saquinavir, and Efavirenz, but Not Nevirapine, Inhibit Bile Acid Transport in Human and Rat Hepatocytes. Journal of Pharmacology and Experimental Therapeutics. 318(3). 1068–1075. 79 indexed citations

13.

Zamek‐Gliszczynski, Maciej J., Ken-ichi Nezasa, Xianbin Tian, et al.. (2006). The Important Role of Bcrp (Abcg2) in the Biliary Excretion of Sulfate and Glucuronide Metabolites of Acetaminophen, 4-Methylumbelliferone, and Harmol in Mice. Molecular Pharmacology. 70(6). 2127–2133. 74 indexed citations

14.

Zamek‐Gliszczynski, Maciej J., Keith Hoffmaster, Joan E. Humphreys, et al.. (2006). Differential Involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in Biliary Excretion of 4-Methylumbelliferyl Glucuronide and Sulfate in the Rat. Journal of Pharmacology and Experimental Therapeutics. 319(1). 459–467. 65 indexed citations

15.

Tallman, Melanie N., Fay K. Kessler, Judith N. Nielsen, et al.. (2006). The Contribution of Intestinal UDP-Glucuronosyltransferases in Modulating 7-Ethyl-10-hydroxy-camptothecin (SN-38)-Induced Gastrointestinal Toxicity in Rats. Journal of Pharmacology and Experimental Therapeutics. 320(1). 29–37. 22 indexed citations

16.

Zhang, Peijin, Xianbin Tian, Priyamvada Chandra, & Kim L. R. Brouwer. (2005). Role of Glycosylation in Trafficking of Mrp2 in Sandwich-Cultured Rat Hepatocytes. Molecular Pharmacology. 67(4). 1334–1341. 58 indexed citations

17.

Zamek‐Gliszczynski, Maciej J., Keith Hoffmaster, Xianbin Tian, et al.. (2005). MULTIPLE MECHANISMS ARE INVOLVED IN THE BILIARY EXCRETION OF ACETAMINOPHEN SULFATE IN THE RAT: ROLE OF MRP2 AND BCRP1. Drug Metabolism and Disposition. 33(8). 1158–1165. 54 indexed citations

18.

Tian, Xianbin. (2004). Modulation of Multidrug Resistance-Associated Protein 2 (Mrp2) and Mrp3 Expression and Function with Small Interfering RNA in Sandwich-Cultured Rat Hepatocytes. Molecular Pharmacology. 66(4). 1004–1010. 42 indexed citations

19.

Tian, Xianbin, Maciej J. Zamek‐Gliszczynski, Peijin Zhang, & Kim L. R. Brouwer. (2004). Modulation of Multidrug Resistance-Associated Protein 2 (Mrp2) and Mrp3 Expression and Function with Small Interfering RNA in Sandwich-Cultured Rat Hepatocytes. Molecular Pharmacology. 66(4). 1004–1010. 12 indexed citations

20.

Tian, Xianbin, et al.. (2002). The Mold-Specific MS8 Gene Is Required for Normal Hypha Formation in the Dimorphic Pathogenic Fungus Histoplasma capsulatum. Eukaryotic Cell. 1(2). 249–256. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact